According to Figure 2A, the expression of CHRDL1 was markedly downregulated in most cancers but upregulated in glioma, brain lower grade glioma, pancreatic adenocarcinoma, acute myeloid leukemia and thymoma. Here, CHRDL1 is linked to cancer.